Xtant Medical Holdings price target set at $1 by LUCID Capital Markets
Benzinga reports a ratings action for Xtant Medical Holdings, with a $1.00 per-share price target announced by LUCID Capital Markets.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.